Know what you own, ITNS is a Monster in the making:
Smitter DD;
About 2 1/2 years ago ITNS created a pharmaceutical division. They brought on board the Famous Dr Charles Hensley.. The great doctor is the founder and Creator of ZICAM cold Remedy. I am sure you have heard of it. Well about 2 1/2 years ago Dr Hensley who is a Homeopathic Genius embarked on this great product and Idea. It's called Emesyl. Emesyl treats nausea brought on by all sorts of illnesses. One in Particular is Chemo Therapy. Most people who suffer from Nausea cannot take medicine Orally because they Vomit it up. Dr Hensley has created a Nasal Passage treatment. It has already went through all the testing needed. It has all the packaging done. Emesyl is ready for Manufacturing and distribution. It is Patented and will be granted in 2 weeks.
Dr Hensley because of ZICAM already has all the connections to get into every Big Box store we desire.
Next we all were shocked and very happy that Dr Hensley and ITNS have decided to also get into the Medical Marijuana business as well. California law allows Medical Marijuana and it's also a homeopathic drug. We don't know yet all the details but what ever is coming is going to be huge based on our recent licensing deal with MYEC that gives us total control of Southern California.
It is also anticipated that ITNS is on their way or will be creating a Nasal based Marijuana drug to help fight Tumor treatments and other illnesses when folks are too sick to smoke it. They will be able to inject in through there nasal passages. This is pure speculation but many feel it's in the works.
Lastly Company Officials own about 35-45% of the shares restricted.
I hope this gives you a great start on your DD of ITNS.
WE HAVE A GEM HERE!
Pronew Chart:
Surehands DD:
ITNS THE NEXT SPLI:
Price prediction:
Short Term - .05 Mid Term -10 Long Term -.25+
ITNS Waiting For News on:
1- Revolutionary MJ drug treatment methodology. 2- Emesyl Distribution Contract 3- Emesyl Manufacturing Roll out 4- MYEC Application ROI Implementation
Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.
Intranasal drug delivery - General principles
The nasal cavity's easily accessible, rich vascular plexus permits topically administered drugs to rapidly achieve effective blood levels while avoiding intravenous catheters. This is most effectively accomplished by distributing drug solutions as a mist rather than as larger droplets which may aggregate and run off instead of being absorbed.
Because of this easily accessed vascular bed, nasal administration of medications is emerging as a promising method of delivering medications directly to the blood stream. This method of delivery can eliminate the need for intravenous catheters while still achieving rapid, effective blood levels of the medication administered.
Administering medications via the nasal mucosal offers several advantages:
1 -The rich vascular plexus of the nasal cavity provides a direct route into the blood stream for medications that easily cross mucous membranes.
2 -This direct absorption into the blood stream avoids gastrointestinal destruction and hepatic first pass metabolism (destruction of drugs by liver enzymes) allowing more drug to be cost-effectively, rapidly, and predictably bioavailable than if it were administered orally.
3 -For many IN medications the rates of absorption and plasma concentrations are comparable to intravenous administration, and are typically better than subcutaneous or intramuscular routes.
Note the below is an extremely important advantage:
4 - Ease, convenience and safety: IN drug administration is essentially painless, and does not require sterile technique, intravenous catheters or other invasive devices, and it is immediately and readily available for all patients.
5 -Because the nasal mucosa is nearby the brain, cerebrospinal fluid (CSF) drug concentrations can exceed plasma concentrations. IN administration may rapidly achieve therapeutic brain and spinal cord (CNS) drug concentrations.
Intranasal (IN) medication delivery is simply another option or method to deliver therapeutic medications to the patient’s blood stream to achieve a desired clinical effect. It is a tool in the therapeutic armamentarium just as oral, rectal, sublingual, intramuscular and intravenous delivery methods are also tools to deliver medications. 1 Painless 2 Ease of use 3 No shot needed 4 Avoids first pass metabolism - improving bioavailability over oral and rectal doses 5 Nose-brain pathway allows direct delivery to the cerebral spinal fluid 6 Compliance not an issue - easy and fast to deliver to any patient
In general, medications that consist of small, simple, lipophilic molecules will cross membranes most easily. Having a pH near physiologic helps as well. Finally, if the drug concentration is such that it can be delivered in a reasonable volume to the nose so no runoff into the throat or out the nostril occurs, then more absorption and higher bioavailability is possible.
BOOM BOOM SHAKALAKA:
ITNS
THE NEXT SPLI
Soon all doctors will approve a Nasal MJ solution (Emesyl) to help relief nausea and pain associated with Chronic diseases:
Arkansans for Compassionate Care
Arkansans for Compassionate Care is a coalition of concerned physicians, patients, and allies who agree that sick and dying patients should have access to medical marijuana with a doctor's recommendation.
For thousands of chronically-ill Arkansans, the pain and nausea relief afforded by marijuana helps them live comfortably without harmful side effects. But marijuana is currently unregulated and not legally available.
Arkansans for Compassionate Care says it offers a better choice: controlled access to a medicine that is proven to be both safe and effective, especially against the debilitating effects of chronic illness and harsh medical treatments.
Size of the Boomer and Senior Markets:
1. 77 million people were born between 1946 and 1964, which is defined as the baby boomer era (U.S. Census). 2. The first baby boomer turned 65 on January 1, 2011. 3. An American turns 50 every 7 seconds—that's more than 12,500 people every day (U.S. Census). 4. The senior age group is now, for the first time, the largest in terms of size and percent of the population in the U.S. This age group grew at a faster rate than the total population between 2000 and 2010, according to a 2010 Census brief. 5. More people were 65 years and over in 2010 than in any previous census. Between 2000 and 2010, the population 65 years and over increased at a faster rate (15.1%) than the total U.S population (9.7%). 6. By 2015, those aged 50 and older will represent 45% of the U.S. population (AARP). 7. Baby Boomers make up 35% of the American adult population (Scarborough). 8. By 2030, the 65-plus population will double to about 71.5 million, and by 2050 will grow to 86.7 million people (U.S. Census). 9. In 2050, the number of Americans aged 65 and older is projected to be 88.5 million, more than double its projected population of 40.2 million in 2010.
The Health Conscious Boomer
1. In the next ten years, U.S. baby boomers will increase their annual spending on wellness-based services from approximately $200M to $1 trillion (Paul Zane Pilzer, The Next Trillion). 2. Americans 55+ are the fastest-growing age group among gym members, up more than 266% since 1987 (IBISWorld). 3. 82% of adults aged 50+ who use the Internet research health and wellness information online (Pew and American Life Project). 4. Throughout 2012, more than half of U.S. online consumers used fitness electronics, and more then one-third planned on buying a health-related gadget in 2013 (CEA).
News 
Market Data 
Discover 
AI
